1887

Abstract

The 3a protein of severe acute respiratory syndrome (SARS)-associated coronavirus is expressed and transported to the plasma membrane in tissue cells of infected patients. Its short N-terminal ectodomain was found to elicit strong humoral responses in half of the patients who had recovered from SARS. The ectodomain-specific antibodies from the convalescent-phase plasma readily recognized and induced destruction of 3a-expressing cells in the presence of the human complement system, demonstrating their potential ability to provide immune protection by recognizing and eliminating SARS coronavirus-infected cells that express the target protein. In addition, when coupled to a carrier protein, the ectodomain peptide elicited 3a-specific antibodies in mice and rabbit at high titres. These results showed that the N terminus of the 3a protein is highly immunogenic and elicits potentially protective humoral responses in infected patients. Therefore, the short extracellular domain may be a valuable immunogen in the development of a vaccine for infectious SARS.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81078-0
2006-02-01
2020-10-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/2/369.html?itemId=/content/journal/jgv/10.1099/vir.0.81078-0&mimeType=html&fmt=ahah

References

  1. Bisht H., Roberts A., Vogel L., Bukreyev A., Collins P. L., Murphy B. R., Subbarao K., Moss B. 2004; Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A 101:6641–6646 [CrossRef]
    [Google Scholar]
  2. Buchholz U. J., Bukreyev A., Yang L., Lamirande E. W., Murphy B. R., Subbarao K., Collins P. L. 2004; Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U S A 101:9804–9809 [CrossRef]
    [Google Scholar]
  3. Chang M.-S., Lu Y.-T., Ho S.-T. & 11 other authors 2004; Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochem Biophys Res Comm 314:931–936 [CrossRef]
    [Google Scholar]
  4. Chen Z., Pei D., Jiang L. 11 other authors 2004; Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Chem 50:988–995 [CrossRef]
    [Google Scholar]
  5. Chinese SARS Molecular Epidemiology Consortium 2004; Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303:1666–1669 [CrossRef]
    [Google Scholar]
  6. Drosten C., Günther S., Preiser W. & 23 other authors 2003; Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967–1976 [CrossRef]
    [Google Scholar]
  7. Gao W., Tamin A., Soloff A., D'Aiuto L., Nwanegbo E., Robbins P. D., Bellini W. J., Barratt-Boyes S., Gambotto A. 2003; Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362:1895–1896 [CrossRef]
    [Google Scholar]
  8. Guo J.-P., Petric M., Campbell W., McGeer P. L. 2004; SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology 324:251–256 [CrossRef]
    [Google Scholar]
  9. He Y., Zhou Y., Wu H., Luo B., Chen J., Li W., Jiang S. 2004; Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol 173:4050–4057 [CrossRef]
    [Google Scholar]
  10. Ito N., Mossel E. C., Narayanan K., Popov V. L., Huang C., Inoue T., Peters C. J., Makino S. 2005; Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J Virol 79:3182–3186 [CrossRef]
    [Google Scholar]
  11. Johnston R. E. 2004; A candidate vaccine for severe acute respiratory syndrome. N Engl J Med 351:827–828 [CrossRef]
    [Google Scholar]
  12. Ksiazek T. G., Erdman D., Goldsmith C. S. & 24 other authors 2003; A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953–1966 [CrossRef]
    [Google Scholar]
  13. Leung D. T. M., Tam F. C. H., Ma C. H., Chan P. K. S., Cheung J. L. K., Niu H., Tam J. S. L., Lim P. L. 2004; Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 190:379–386 [CrossRef]
    [Google Scholar]
  14. Liu X., Shi Y., Li P., Li L., Yi Y., Ma Q., Cao C. 2004; Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clin Diagn Lab Immunol 11:227–228
    [Google Scholar]
  15. Peiris J. S. M., Lai S. T., Poon L. L. M. & 14 other authors 2003; Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319–1325 [CrossRef]
    [Google Scholar]
  16. Poutanen S. M., Low D. E., Henry B. & 19 other authors 2003; Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348:1995–2005 [CrossRef]
    [Google Scholar]
  17. Rottier P. J. M. 1995; The coronavirus membrane glycoprotein. In The Coronaviridae pp  115–139 Edited by Siddell S. G. New York: Plenum;
    [Google Scholar]
  18. Ruan Y., Wei C. L., Ee L. A. & 17 other authors 2003; Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361:1779–1785 [CrossRef]
    [Google Scholar]
  19. Shi Y., Wan Z., Li L., Li P., Li C., Ma Q., Cao C. 2004; Antibody responses against SARS-coronavirus and its nucleocapsid in SARS patients. J Clin Virol 31:66–68 [CrossRef]
    [Google Scholar]
  20. Siddell S. G. 1995; The small-membrane protein. In The Coronaviridae pp  181–189 Edited by Siddell S. G. New York: Plenum;
    [Google Scholar]
  21. Subbarao K., McAuliffe J., Vogel L. 7 other authors 2004; Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 78:3572–3577 [CrossRef]
    [Google Scholar]
  22. Tan Y.-J., Goh P.-Y., Fielding B. C. & 9 other authors (2004a). Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol 11:362–371
    [Google Scholar]
  23. Tan Y.-J., Teng E., Shen S. & 7 other authors 2004b; A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J Virol 78:6723–6734 [CrossRef]
    [Google Scholar]
  24. Wang J., Wen J., Li J. 30 other authors 2003; Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem 49:1989–1996 [CrossRef]
    [Google Scholar]
  25. Yang Z.-Y., Kong W.-P., Huang Y., Roberts A., Murphy B. R., Subbarao K., Nabel G. J. 2004; A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428:561–564 [CrossRef]
    [Google Scholar]
  26. Yang Z.-Y., Werner H. C., Kong W.-P., Leung K., Traggiai E., Lanzavecchia A., Nabel G. J. 2005; Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A 102:797–781 [CrossRef]
    [Google Scholar]
  27. Yeh S.-H., Wang H.-Y., Tsai C.-Y. & 8 other authors 2004; Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A 101:2542–2547 [CrossRef]
    [Google Scholar]
  28. Yu C.-J., Chen Y.-C., Hsiao C.-H. & 9 other authors 2004; Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus. FEBS Lett 565:111–116 [CrossRef]
    [Google Scholar]
  29. Zeng R., Yang R.-F., Shi M.-D. & 31 other authors 2004; Characterization of the 3a protein of SARS-associated coronavirus in infected Vero E6 cells and SARS patients. J Mol Biol 341:271–279 [CrossRef]
    [Google Scholar]
  30. Zhao P., Ke J.-S., Qin Z.-L., Ren H., Zhao L.-J., Yu J. G., Gao J., Zhu S.-Y., Qi Z.-T. 2004; DNA vaccine of SARS-Cov S gene induces antibody response in mice. Acta Biochim Biophys Sin 36:37–41 [CrossRef]
    [Google Scholar]
  31. Zhong X., Yang H., Guo Z.-F. & 13 other authors 2005; B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol 79:3401–3408 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81078-0
Loading
/content/journal/jgv/10.1099/vir.0.81078-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error